| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Caris Life Sciences, Inc. | Director | Common Stock | 10.3M | Jun 20, 2025 | By CLS-PF-SPE, LLC | ||
| Caris Life Sciences, Inc. | Director | Common Stock | 100K | Jun 17, 2025 | By Family Trust | ||
| Caris Life Sciences, Inc. | Director | Common Stock | 16.1K | Jun 17, 2025 | Direct | ||
| Caris Life Sciences, Inc. | Director | Stock Option | 2.5K | Feb 27, 2025 | Direct | ||
| Caris Life Sciences, Inc. | Director | Series A Preferred Stock | 0 | Jun 20, 2025 | By CLS-PF-SPE, LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CAI | Caris Life Sciences, Inc. | Jun 17, 2025 | 0 | $0 | 3 | Jun 17, 2025 | Director |
| CAI | Caris Life Sciences, Inc. | Feb 27, 2025 | 4 | $0 | 4 | Jun 23, 2025 | Director |